Neuromuscular Disorders
Volume 19, Issue 5 , Pages 366-378 , May 2009

Aberrant development of neuromuscular junctions in glycosylation-defective Largemyd mice

  • Ruth Herbst

      Affiliations

    • Center for Brain Research, Medical University of Vienna, Spitalgasse 4, A-1090 Vienna, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 1 4277 62962; fax: +43 1 4277 62899.
    • ,
  • Thomas Iskratsch

      Affiliations

    • Center of Anatomy and Cell Biology, Neuromuscular Research Department, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Ewald Unger

      Affiliations

    • Center for Biomedical Engineering and Physics, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Reginald E. Bittner

      Affiliations

    • Center of Anatomy and Cell Biology, Neuromuscular Research Department, Medical University of Vienna, A-1090 Vienna, Austria

Received 2 November 2007 ,Revised 17 February 2009 ,Accepted 27 February 2009.

References 

  1. Martin PT, Sanes JR. Role for a synapse-specific carbohydrate in agrin-induced clustering of acetylcholine receptors. Neuron. 1995;14:743–754
  2. Martin PT, Scott LJ, Porter BE, Sanes JR. Distinct structures and functions of related pre- and postsynaptic carbohydrates at the mammalian neuromuscular junction. Mol Cell Neurosci. 1999;13:105–118
  3. Martin PT. Glycobiology of the synapse. Glycobiology. 2002;12:1R–7R
  4. Gehle VM, Walcott EC, Nishizaki T, Sumikawa K. N-glycosylation at the conserved sites ensures the expression of properly folded functional ACh receptors. Brain Res Mol Brain Res. 1997;45:219–229
  5. Blount P, Merlie JP. Mutational analysis of muscle nicotinic acetylcholine receptor subunit assembly. J Cell Biol. 1990;111:2613–2622
  6. Merlie JP, Sebbane R, Tzartos S, Lindstrom J. Inhibition of glycosylation with tunicamycin blocks assembly of newly synthesized acetylcholine receptor subunits in muscle cells. J Biol Chem. 1982;257:2694–2701
  7. Prives J, Bar-Sagi D. Effect of tunicamycin, an inhibitor of protein glycosylation, on the biological properties of acetylcholine receptor in cultured muscle cells. J Biol Chem. 1983;258:1775–1780
  8. Tsen G, Halfter W, Kroger S, Cole GJ. Agrin is a heparan sulfate proteoglycan. J Biol Chem. 1995;270:3392–3399
  9. Winzen U, Cole GJ, Halfter W. Agrin is a chimeric proteoglycan with the attachment sites for heparan sulfate/chondroitin sulfate located in two multiple serine-glycine clusters. J Biol Chem. 2003;278:30106–30114
  10. Burgess RW, Nguyen QT, Son YJ, Lichtman JW, Sanes JR. Alternatively spliced isoforms of nerve- and muscle-derived agrin: their roles at the neuromuscular junction. Neuron. 1999;23:33–44
  11. Watty A, Burden SJ. MuSK glycosylation restrains MuSK activation and acetylcholine receptor clustering. J Biol Chem. 2002;277:50457–50462
  12. Cohn RD, Campbell KP. Molecular basis of muscular dystrophies. Muscle Nerve. 2000;23:1456–1471
  13. Adams ME, Kramarcy N, Fukuda T, Engel AG, Sealock R, Froehner SC. Structural abnormalities at neuromuscular synapses lacking multiple syntrophin isoforms. J Neurosci. 2004;24:10302–10309
  14. Deconinck AE, Potter AC, Tinsley JM, Wood SJ, Vater R, Young C, et al. Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. J Cell Biol. 1997;136:883–894
  15. Patton BL, Cunningham JM, Thyboll J, Kortesmaa J, Westerblad H, Edstrom L, et al. Properly formed but improperly localized synaptic specializations in the absence of laminin α4. Nat Neurosci. 2001;4:597–604
  16. Williamson RA, Henry MD, Daniels KJ, Hrstka RF, Lee JC, Sunada Y, et al. Dystroglycan is essential for early embryonic development: disruption of Reichert’s membrane in Dag1-null mice. Hum Mol Genet. 1997;6:831–841
  17. Cote PD, Moukhles H, Lindenbaum M, Carbonetto S. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat Genet. 1999;23:338–342
  18. Jacobson C, Cote PD, Rossi SG, Rotundo RL, Carbonetto S. The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane. J Cell Biol. 2001;152:435–450
  19. Grewal PK, Holzfeind PJ, Bittner RE, Hewitt JE. Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse. Nat Genet. 2001;28:151–154
  20. Holzfeind PJ, Grewal PK, Reitsamer HA, Kechvar J, Lassmann H, Hoeger H, et al. Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large(myd) mouse defines a natural model for glycosylation-deficient muscle–eye–brain disorders. Hum Mol Genet. 2002;11:2673–2687
  21. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, et al. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature. 2002;418:417–422
  22. Peyrard M, Seroussi E, Sandberg-Nordqvist AC, Xie YG, Han FY, Fransson I, et al. The human LARGE gene from 22q12.3-q13.1 is a new, distinct member of the glycosyltransferase gene family. Proc Natl Acad Sci USA. 1999;96:598–603
  23. Grewal PK, Hewitt JE. Glycosylation defects: a new mechanism for muscular dystrophy?. Hum Mol Genet. 2003;12(Spec No. 2):R259–R264
  24. Barresi R, Campbell KP. Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci. 2006;119:199–207
  25. Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, et al. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature. 2002;418:422–425
  26. Herbst R, Avetisova E, Burden SJ. Restoration of synapse formation in Musk mutant mice expressing a Musk/Trk chimeric receptor. Development. 2002;129:5449–5460
  27. Herbst R, Burden SJ. The juxtamembrane region of MuSK has a critical role in agrin-mediated signaling. Embo J. 2000;19:67–77
  28. Zhu X, Lai C, Thomas S, Burden SJ. Neuregulin receptors, erbB3 and erbB4, are localized at neuromuscular synapses. Embo J. 1995;14:5842–5848
  29. Koelle GB, Friedenwald JS. A biochemical method for localizing cholinesterase activity. Proc Soc Ex Biol Methods. 1949;70:617–622
  30. Ryder-Cook AS, Sicinski P, Thomas K, Davies KE, Worton RG, Barnard EA, et al. Localization of the mdx mutation within the mouse dystrophin gene. Embo J. 1988;7:3017–3021
  31. Grady RM, Teng H, Nichol MC, Cunningham JC, Wilkinson RS, Sanes JR. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell. 1997;90:729–738
  32. DeChiara TM, Bowen DC, Valenzuela DM, Simmons MV, Poueymirou WT, Thomas S, et al. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell. 1996;85:501–512
  33. Gautam M, Noakes PG, Mudd J, Nichol M, Chu GC, Sanes JR, et al. Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice. Nature. 1995;377:232–236
  34. Gautam M, Noakes PG, Moscoso L, Rupp F, Scheller RH, Merlie JP, et al. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell. 1996;85:525–535
  35. Peters MF, Kramarcy NR, Sealock R, Froehner SC. β2-Syntrophin: localization at the neuromuscular junction in skeletal muscle. Neuroreport. 1994;5:1577–1580
  36. Noda M, Takahashi H, Tanabe T, Toyosato M, Furutani Y, Hirose T, et al. Primary structure of α-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence. Nature. 1982;299:793–797
  37. Kao PN, Dwork AJ, Kaldany RR, Silver ML, Wideman J, Stein S, et al. Identification of the α-subunit half-cystine specifically labeled by an affinity reagent for the acetylcholine receptor binding site. J Biol Chem. 1984;259:11662–11665
  38. Martin PT. Glycobiology of the neuromuscular junction. J Neurocytol. 2003;32:915–929
  39. Blanchard D, Capon C, Leroy Y, Cartron JP, Fournet B. Comparative study of glycophorin A derived O-glycans from human Cad, Sd(a+) and Sd(a-) erythrocytes. Biochem J. 1985;232:813–818
  40. Donald AS, Yates AD, Soh CP, Morgan WT, Watkins WM. A blood group Sda-active pentasaccharide isolated from Tamm–Horsfall urinary glycoprotein. Biochem Biophys Res Commun. 1983;115:625–631
  41. Piller V, Piller F, Cartron JP. Comparison of the carbohydrate-binding specificities of seven N-acetyl-d-galactosamine-recognizing lectins. Eur J Biochem. 1990;191:461–466
  42. Lee Y, Kameya S, Cox GA, Hsu J, Hicks W, Maddatu TP, et al. Ocular abnormalities in Large(myd) and Large(vls) mice, spontaneous models for muscle, eye, and brain diseases. Mol Cell Neurosci. 2005;30:160–172
  43. Levedakou EN, Chen XJ, Soliven B, Popko B. Disruption of the mouse Large gene in the enr and myd mutants results in nerve, muscle, and neuromuscular junction defects. Mol Cell Neurosci. 2005;28:757–769
  44. Taniguchi M, Kurahashi H, Noguchi S, Fukudome T, Okinaga T, Tsukahara T, et al. Aberrant neuromuscular junctions and delayed terminal muscle fiber maturation in α-dystroglycanopathies. Hum Mol Genet. 2006;15:1279–1289
  45. Stalberg E, Falck B. The role of electromyography in neurology. Electroencephalogr clin neurophysiol. 1997;103:579–598
  46. Rafuse VF, Polo-Parada L, Landmesser LT. Structural and functional alterations of neuromuscular junctions in NCAM-deficient mice. J Neurosci. 2000;20:6529–6539
  47. Slater CR. Structural factors influencing the efficacy of neuromuscular transmission. Ann NY Acad Sci. 2008;1132:1–12
  48. Kummer TT, Misgeld T, Lichtman JW, Sanes JR. Nerve-independent formation of a topologically complex postsynaptic apparatus. J Cell Biol. 2004;164:1077–1087
  49. Sugiyama JE, Glass DJ, Yancopoulos GD, Hall ZW. Laminin-induced acetylcholine receptor clustering: an alternative pathway. J Cell Biol. 1997;139:181–191
  50. Lin W, Dominguez B, Yang J, Aryal P, Brandon EP, Gage FH, et al. Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism. Neuron. 2005;46:569–579
  51. Misgeld T, Kummer TT, Lichtman JW, Sanes JR. Agrin promotes synaptic differentiation by counteracting an inhibitory effect of neurotransmitter. Proc Natl Acad Sci USA. 2005;102:11088–11093
  52. Saito F, Moore SA, Barresi R, Henry MD, Messing A, Ross-Barta SE, et al. Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron. 2003;38:747–758
  53. Reddy LV, Koirala S, Sugiura Y, Herrera AA, Ko CP. Glial cells maintain synaptic structure and function and promote development of the neuromuscular junction in vivo. Neuron. 2003;40:563–580
  54. Wolpowitz D, Mason TB, Dietrich P, Mendelsohn M, Talmage DA, Role LW. Cysteine-rich domain isoforms of the neuregulin-1 gene are required for maintenance of peripheral synapses. Neuron. 2000;25:79–91
  55. Mishina M, Takai T, Imoto K, Noda M, Takahashi T, Numa S, et al. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature. 1986;321:406–411
  56. Sine SM. Identification of equivalent residues in the gamma, delta, and epsilon subunits of the nicotinic receptor that contribute to α-bungarotoxin binding. J Biol Chem. 1997;272:23521–23527
  57. Poulter L, Earnest JP, Stroud RM, Burlingame AL. Structure, oligosaccharide structures, and posttranslationally modified sites of the nicotinic acetylcholine receptor. Proc Natl Acad Sci USA. 1989;86:6645–6649
  58. Shoji H, Takahashi N, Nomoto H, Ishikawa M, Shimada I, Arata Y, et al. Detailed structural analysis of asparagine-linked oligosaccharides of the nicotinic acetylcholine receptor from Torpedo californica. Eur J Biochem. 1992;207:631–641
  59. Mishina M, Tobimatsu T, Imoto K, Tanaka K, Fujita Y, Fukuda K, et al Location of functional regions of acetylcholine receptor α-subunit by site-directed mutagenesis. Nature. 1985;313:364–369
  60. Sumikawa K, Gehle VM. Assembly of mutant subunits of the nicotinic acetylcholine receptor lacking the conserved disulfide loop structure. J Biol Chem. 1992;267:6286–6290
  61. Gehle VM, Sumikawa K. Site-directed mutagenesis of the conserved N-glycosylation site on the nicotinic acetylcholine receptor subunits. Brain Res Mol Brain Res. 1991;11:17–25
  62. Barresi R, Michele DE, Kanagawa M, Harper HA, Dovico SA, Satz JS, et al. LARGE can functionally bypass α-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat Med. 2004;10:696–703
  63. Tollefsen SE, Kornfeld R. The B4 lectin from Vicia villosa seeds interacts with N-acetylgalactosamine residues α-linked to serine or threonine residues in cell surface glycoproteins. J Biol Chem. 1983;258:5172–5176
  64. Tollefsen SE, Kornfeld R. Isolation and characterization of lectins from Vicia villosa. Two distinct carbohydrate-binding activities are present in seed extracts. J Biol Chem. 1983;258:5165–5171
  65. Puri KD, Gopalakrishnan B, Surolia A. Carbohydrate-binding specificity of the Tn-antigen binding lectin from Vicia villosa seeds (VVLB4). FEBS Lett. 1992;312:208–212
  66. Hoyte K, Kang C, Martin PT. Definition of pre- and postsynaptic forms of the CT carbohydrate antigen at the neuromuscular junction: ubiquitous expression of the CT antigens and the CT GalNAc transferase in mouse tissues. Brain Res Mol Brain Res. 2002;109:146–160
  67. Sanes JR, Cheney JM. Lectin binding reveals a synapse-specific carbohydrate in skeletal muscle. Nature. 1982;300:646–647
  68. Xia B, Hoyte K, Kammesheidt A, Deerinck T, Ellisman M, Martin PT. Overexpression of the CT GalNAc transferase in skeletal muscle alters myofiber growth, neuromuscular structure, and laminin expression. Dev Biol. 2002;242:58–73
  69. Endo T. O-mannosyl glycans in mammals. Biochim Biophys Acta. 1999;1473:237–246
  70. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 1992;355:696–702

PII: S0960-8966(09)00057-1

doi: 10.1016/j.nmd.2009.02.011

Neuromuscular Disorders
Volume 19, Issue 5 , Pages 366-378 , May 2009

Article Tools

* Image Usage & Resolution